Veterinary CRO and CDMO Market Research Report: By Application (Drug Development, Toxicology and Safety, Pharmacokinetics and Metabolism, Bioanalysis, Manufacturing), By Service Type (Discovery and Development, Clinical Trial Support, Manufacturing and Packaging, Regulatory Affairs), By Therapeutic Area (Oncology, Cardiovascular, Neurology, Immunology, Infectious Diseases), By Animal Type (Small Animals (Dogs, Cats), Livestock (Cattle, Pigs, Poultry), Aquatic Animals (Fish, Shrimp), Laboratory Animals (Mice, Rats)) and By Regional (North Am

Global Veterinary CRO and CDMO Market Overview:

As per MRFR analysis, the Veterinary CRO and CDMO Market Size was estimated at 12.87 (USD Billion) in 2022. The Veterinary CRO and CDMO Market Industry is expected to grow from 13.73 (USD Billion) in 2023 to 24.6 (USD Billion) by 2032. The Veterinary CRO and CDMO Market CAGR (growth rate) is expected to be around 6.69% during the forecast period (2024 - 2032).

Key Veterinary CRO and CDMO Market Trends Highlighted

The Veterinary CRO and CDMO market is experiencing ongoing advancements driven by the growing demand for animal health and welfare, particularly in emerging regions. Key market drivers include increased pet ownership, rising disposable income levels, and heightened awareness of animal health. Contract Research Organizations (CROs) and Contract Development and Manufacturing Organizations (CDMOs) play a vital role in providing specialized services and support to veterinary pharmaceutical companies.Opportunities for growth in this market lie in the expansion of CRO and CDMO capabilities to cater to the growing demand for complex veterinary clinical trials, specialized manufacturing techniques, and regulatory compliance services. The increasing adoption of advanced technologies such as AI and machine learning in drug development and manufacturing processes is also creating new avenues for innovation and efficiency.Recent trends in the Veterinary CRO and CDMO market include strategic partnerships and acquisitions aimed at expanding service offerings and geographical reach. Additionally, the growing emphasis on personalized medicine and precision diagnostics for animals is opening up avenues for targeted treatments and therapies, further driving market growth.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Veterinary CRO and CDMO Market Drivers

Increasing Demand for Veterinary Pharmaceuticals

The ever-increasing global population coupled with the growing concern towards animals in terms of health and welfare are arguably some of the key factors that are driving the demand and subsequent growth of the market. In addition to this, the increased prevalence of chronic diseases, including diabetes, cancer, and arthritis among animals, is contributing to the expansion of the market. Furthermore, the growing popularity of pets and the increased rates of animal ownership, especially for companion animals such as dogs canine and feline, are key factors that are driving the demand for animal drugs, thereby leading to the growth of the Veterinary CRO And CDMO Market Industry.

Growing Outsourcing Trend in Veterinary Drug Development

One of the major factors that are expected to drive the Veterinary CRO And CDMO Market Industry is the rising outsourcing trend in veterinary drug development. Companies that are engaged in developing veterinary drugs prefer to outsource the tasks to CROs and CDMOs to minimize the costs and focus on their core competencies. CROs and CDMOs offer various services including preclinical and clinical research, regulatory affairs as well as manufacturing.The trend is expected to continue in the future as well because veterinary pharmaceutical companies are always looking for ways to improve their efficiency and reduce their costs.

Technological Advancements in Veterinary Drug Development

Technological advancement in the development of veterinary drugs is one of the critical reasons contributing to the growth of the Veterinary CRO And CDMO Market Industry. The technological advancements include the development of new drug delivery systems such as nanotechnology and gene therapy. These new technologies are helping in the development of more effective and targeted veterinary drugs. Moreover, artificial intelligence and machine learning are helping in speeding up the process of drug development.Thus, technological advancement is expected to have a high impact on driving the veterinary CRO and CDMO market industry in the next few years.

Veterinary CRO and CDMO Market Segment Insights:

Veterinary CRO and CDMO Market Application Insights

The Veterinary CRO And CDMO Market is segmented into Drug Development, Toxicology and Safety, Pharmacokinetics and Metabolism, Bioanalysis, and Manufacturing. Among these segments, Drug Development is expected to hold the largest market share of around 40% in 2024, owing to the rising demand for veterinary drugs and the increasing number of veterinary clinical trials. The Toxicology and Safety segment is expected to grow at the fastest rate during the forecast period due to the increasing need for safety assessments of veterinary drugs and the growing awareness of animal welfare.The Veterinary CRO And CDMO Market is driven by factors such as the rising prevalence of animal diseases, the increasing demand for companion animals, and the growing awareness of animal health and welfare. The market is expected to be driven by the increasing demand for veterinary drugs and the growing number of veterinary clinical trials. North America is expected to hold the largest market share in the Veterinary CRO And CDMO Market, followed by Europe and Asia-Pacific. The North American market is driven by the high prevalence of companion animals and the well-developed veterinary healthcare industry.The European market is expected to grow at a steady pace due to the increasing demand for veterinary drugs and the rising awareness of animal welfare. The Asia-Pacific market is expected to witness the fastest growth, owing to the rising prevalence of animal diseases and the increasing demand for companion animals. Major players in the Veterinary CRO And CDMO Market include Charles River Laboratories International, Inc., Covance Inc., Eurofins Scientific SE, and Merck Co., Inc. These companies offer a wide range of veterinary CRO and CDMO services, including drug development, toxicology and safety, pharmacokinetics and metabolism, bioanalysis, and manufacturing.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Veterinary CRO and CDMO Market Service Type Insights

The Service Type of the Veterinary CRO And CDMO Market is further divided into Discovery and Development, Clinical Trial Support, Manufacturing and Packaging, and Regulatory Affairs. The Discovery and Development segment was the most popular segment in 2023, and it is expected to lead the market during the forecast period as well, making a varying proportion of the Veterinary CRO And CDMO Market revenue. The growth of this segment is determined by the demand for innovative veterinary products and the necessity of undertaking an economic and effective drug development process.The Clinical Trial Support segment is also likely to develop rather quickly as it is associated with the increased number of clinical trials and the need for professional support that will allow an increase in the final product’s safety and effectiveness. The demand for high-quality veterinary products will predispose the popularity of the Manufacturing and Packaging segment of the Veterinary CRO And CDMO Market, as there will also become a high need to develop specialized packaging solutions that will secure the necessary stability of the final drugs.Finally, the importance of the Regulatory Affairs segment can hardly be underestimated as its existence allows to secure compliance with the specific regulatory demands and allows the product’s approval. Due to the fact that more and more regulations appear in the industry, stable growth of the segment is expected.

Veterinary CRO and CDMO Market Therapeutic Area Insights

The Therapeutic Area segment is a crucial aspect of the Veterinary CRO And CDMO Market, with each therapeutic area representing a distinct set of diseases and treatment modalities. Oncology, Cardiovascular, Neurology, Immunology, and Infectious Diseases are among the key therapeutic areas in the veterinary CRO and CDMO market. Oncology, focused on cancer treatment, is a significant therapeutic area due to the rising prevalence of cancer in companion animals. Veterinary CROs and CDMOs play a vital role in developing and testing novel cancer therapies for animals.The global veterinary oncology market is projected to reach USD 3.24 billion by 2024, growing at a CAGR of 7.5%. Cardiovascular diseases affecting the heart and circulatory system are another major therapeutic area in the veterinary CRO and CDMO market. With the increasing adoption of companion animals, the demand for advanced cardiovascular treatments is growing. The global veterinary cardiovascular market is expected to reach USD 1.96 billion by 2024, exhibiting a CAGR of 6.2%. Neurology, dealing with disorders of the nervous system, is a specialized therapeutic area in the veterinary CRO and CDMO market.The rising incidence of neurological diseases in animals has led to an increased demand for CRO and CDMO services. The global veterinary neurology market is anticipated to reach USD 1.25 billion by 2024, growing at a CAGR of 5.8%. Immunology, focusing on diseases related to the immune system, is a growing therapeutic area in the veterinary CRO and CDMO market. With the increasing understanding of the immune system in animals, there is a growing demand for CRO and CDMO services for developing and testing immunotherapies. The global veterinary immunology market is projected to reach USD 1.12 billion by 2024, growing at a CAGR of 6.0%.Infectious Diseases, encompassing a wide range of bacterial, viral, and parasitic infections, pose a significant threat to animal health. Veterinary CROs and CDMOs provide critical services in developing and testing vaccines and treatments for infectious diseases. The global veterinary infectious diseases market is expected to reach USD 2.89 billion by 2024, growing at a CAGR of 7.1%. The segmentation of the Therapeutic Area segment provides valuable insights into the specific needs and trends within each therapeutic area, enabling Veterinary CROs and CDMOs to tailor their services and offerings accordingly.

Veterinary CRO and CDMO Market Animal Type Insights

The Animal Type segment is a key driver of growth in the Veterinary CRO And CDMO Market. The growth is attributed to the increasing demand for veterinary services for companion animals, livestock, and aquatic animals. Small animals, such as dogs and cats, accounted for the largest share of the market in 2023, and this trend is expected to continue in the coming years. The growing popularity of pet ownership and increasing awareness of animal welfare are key factors driving the demand for veterinary services for small animals. Livestock, including cattle, pigs, and poultry, is another significant segment of the Veterinary CRO and CDMO Market.The demand for veterinary services for livestock is driven by the need to improve animal health and productivity, as well as to prevent and control animal diseases. Aquatic animals, such as fish and shrimp, are also a growing segment of the market. The increasing demand for seafood and the need to improve aquaculture practices are driving the growth of this segment. Laboratory animals, such as mice and rats, are used in biomedical research and drug development. The demand for veterinary services for laboratory animals is expected to remain steady in the coming years.

Veterinary CRO and CDMO Market Regional Insights

The regional segmentation of the Veterinary CRO And CDMO Market offers valuable insights into the market's geographic distribution and growth patterns. North America is expected to dominate the market in 2023, accounting for a significant share of the Veterinary CRO And CDMO Market revenue. The region's large pet population, advanced veterinary infrastructure, and strong research and development capabilities contribute to its dominance. Europe is another key market, driven by factors such as rising pet ownership rates, increasing awareness of animal health and well-being, and government initiatives to promote animal welfare.The APAC region is anticipated to witness substantial growth in the coming years, attributed to expanding pet ownership, increasing disposable income, and growing awareness of veterinary care. South America and MEA are also expected to contribute to the global market growth, albeit at a slower pace compared to other regions.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Veterinary CRO and CDMO Market Key Players And Competitive Insights:

As the Veterinary CRO and CDMO Market moves further into the 21st century, major players in the industry are constantly seeking to gain a competitive edge. Companies are making large investments in research and development, expanding their product portfolios, and the veterinary cro and cdmo market competitive landscape continues to evolve. Much of the current interest and activity within the sector focuses on the veterinary cro and cdmo market, with a number of the leading participants in the industry focusing on the development and introduction of innovative technologies and other solutions. The overarching factors contributing to this trend include the increasing demand for companion animal health products, the rising incidences of animal diseases, and the increasing awareness of animal welfare. On that note, the veterinary cro and cdmo markets are predicted to be competitive over the next several years.Today, one of the leading companies in the industry is also one of the most comprehensive providers of products and services to the animal health industry. This company focuses heavily on research and development, and in the last year, they made considerable investments in new and improved products and technologies. They have operations in over 50 countries and serve customers in more than 130 countries around the world. The companies in this space are trusted suppliers of quality products and value to their customers.A competitor company might have more of a focus on manufacturing, as it would have strong manufacturing capabilities, enabling it to provide high-quality products in bulk and at competitive costs. In fact, the company is known for these capabilities, and it operates with a strong manufacturing presence around the world. The production department has experienced staff members with the knowledge and resources needed to meet the needs of customers around the world while maintaining competent levels of efficiency. The companies have developed a portfolio of well-regarded products, a large collection of prestigious clients, and a formidable reputation.

Key Companies in the Veterinary CRO and CDMO Market Include:

• Lonza


• WuXi AppTec


• Parexel


• Pra Health Sciences


• Syneos Health


• Pharmaceutical Product Development


• ICON


• Charles River Laboratories


• IQVIA


• InVentiv Health


• Thermo Fisher Scientific


• Eurofins Scientific


• Catalent

Veterinary CRO and CDMO Market Industry Developments

The global Veterinary CRO and CDMO market is expected to grow from USD 13.73 billion in 2023 to USD 24.6 billion by 2032, at a CAGR of 6.69%. The growth of the market is attributed to the increasing demand for veterinary drugs and biologics, the rising prevalence of animal diseases, and the growing adoption of outsourcing by veterinary pharmaceutical companies.Recent news developments in the Veterinary CRO and CDMO market include: In January 2023, Charles River Laboratories acquired Cognate BioServices, a leading provider of viral vector manufacturing services, for USD 260 million. In March 2023, Thermo Fisher Scientific announced the expansion of its veterinary clinical research services in Europe with the opening of a new facility in Lyon, France. In May 2023, WuXi AppTec announced a partnership with Bayer to provide integrated drug development and manufacturing services for veterinary products.These developments indicate the growing importance of the Veterinary CRO and CDMO market and the increasing demand for outsourced services by veterinary pharmaceutical companies.

Veterinary CRO and CDMO Market Segmentation Insights

Veterinary CRO and CDMO Market Application Outlook

• Drug Development


• Toxicology and Safety


• Pharmacokinetics and Metabolism


• Bioanalysis


• Manufacturing

Veterinary CRO and CDMO Market Service Type Outlook

• Discovery and Development


• Clinical Trial Support


• Manufacturing and Packaging


• Regulatory Affairs

Veterinary CRO and CDMO Market Therapeutic Area Outlook

• Oncology


• Cardiovascular


• Neurology


• Immunology


• Infectious Diseases

Veterinary CRO and CDMO Market Animal Type Outlook

• Small Animals (Dogs, Cats)


• Livestock (Cattle, Pigs, Poultry)


• Aquatic Animals (Fish, Shrimp)


• Laboratory Animals (Mice, Rats)

Veterinary CRO and CDMO Market Regional Outlook

• North America


• Europe


• South America


• Asia Pacific


• Middle East and Africa